Pro Medicus stock trades at a price-to-earnings ratio of 64.40

Published on 10/15/2026 at 22:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Meeting is set for November 25, 2026. Pro Medicus stock costs EUR 100.68 on October 15, 2026, minus 0.20 percent versus the ASX prior close.

Valuation and upcoming date

Pro Medicus stock carried a price-to-earnings ratio of 64.40 on October 15, 2026.
The 52-week range stood at AUD 107.75 to AUD 299.19 on October 15, 2026.
Pro Medicus stock costs EUR 100.68 at Lang & Schwarz on October 15, 2026 at 10:25 p.m. CEST, with a minus 0.20 percent move on the ASX versus its prior close.
Market capitalization stood at AUD 17.1 billion on October 15, 2026.

Pro Medicus, AU000000PME8, Illustration mit AI erstellt.

Pro Medicus (ISIN AU000000PME8) carried a price-to-earnings ratio of 64.40 on October 15, 2026, while its market value stood at AUD 17.1 billion. Pro Medicus stock was trading at EUR 100.68 at Lang & Schwarz on October 15, 2026 at 10:25 p.m. CEST, with a minus 0.20 percent move on the ASX versus its prior close.

November 25 meeting

The next dated corporate event is the annual meeting scheduled for November 25, 2026, according to Simply Wall St in an October 1, 2026 entry. The meeting gives investors the next fixed date in the company calendar after its fiscal year ended June 30, 2026.

52-week range spans AUD 107.75 to AUD 299.19

The home-market share price was AUD 163.58 on October 15, 2026 at 3:10 p.m. AEDT. That level sat between a 52-week low of AUD 107.75 and a 52-week high of AUD 299.19. The stock's one-year performance was minus 44.10 percent, making the range more important than the small daily change.

Trading volume reached 252,934 shares against an average of 219,291. The difference equals 15.34 percent above the average, giving the session a measurable volume signal without changing the broader valuation picture.

Valuation and capital base

Pro Medicus had a market capitalization of AUD 17.1 billion and a price-to-earnings ratio of 64.40 on October 15, 2026. Its trailing dividend yield was 0.00 percent. The company says it provides medical imaging software and services to hospitals, imaging centers and health care groups, with shares traded on the Australian Securities Exchange under the symbol PME, as stated on its Pro Medicus investor page.

Comparison with peers

Pro Medicus: minus 0.20 percent, P/E 64.40, market capitalization AUD 17.1 billion.

RadNet (Nasdaq, USD): plus 1.81 percent, P/E minus 262.92, market capitalization USD 5.5 billion.

Sectra (Nasdaq Stockholm, SEK): plus 1.89 percent, P/E 95.84, market capitalization SEK 60.4 billion.

Euro quote after hours

The Lang & Schwarz euro quote places Pro Medicus at EUR 100.68 on October 15, 2026 at 10:25 p.m. CEST. The comparable ASX move was minus 0.20 percent versus the prior close, while the Australian listing stood at AUD 163.58 at 3:10 p.m. AEDT.

The further course of trading is shown by the continuously updated real-time quote of Pro Medicus stock.